Symbol="COCP"
AssetType="Common Stock"
Name="Cocrystal Pharma Inc"
Description="Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic viral diseases. The company is headquartered in Bothell, Washington."
CIK="1412486"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="19805 N. CREEK PARKWAY, BOTHELL, WA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="27672700"
EBITDA="-19455000"
PERatio="None"
PEGRatio="0"
BookValue="3.409"
DividendPerShare="0"
DividendYield="0"
EPS="-4.78"
RevenuePerShareTTM="0.006"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.277"
ReturnOnEquityTTM="-0.465"
RevenueTTM="510000"
GrossProfitTTM="-8794000"
DilutedEPSTTM="-4.78"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.269"
AnalystTargetPrice="9.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="92.45"
PriceToBookRatio="0.453"
EVToRevenue="17.89"
EVToEBITDA="0.577"
Beta="1.208"
num_52WeekHigh="5.4"
num_52WeekLow="1.74"
num_50DayMovingAverage="2.603"
num_200DayMovingAverage="2.437"
SharesOutstanding="10173800"
DividendDate="2018-01-24"
ExDividendDate="None"
symbol="COCP"
open="2.71"
high="2.87"
low="2.70"
price="2.72"
volume="8878.00"
latest_trading_day="2023-08-18"
previous_close="2.74"
change="-0.02"
change_percent="-0.7299%"
aroon_positive_momentum_days="51"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="51"
Volume_recent_avg="56144"
Change_recent_avg="0.02"
Delta_recent_avg="0.17"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="0.56"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="51"
Aroon_momentum_negative="49"
image_negative_thumbnail_id_1="94"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0082.jpeg"
image_negative_thumbnail_id_2="117"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0059.jpeg"
image_neutral_thumbnail_id_1="534"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0065.jpeg"
image_neutral_thumbnail_id_2="587"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0012.jpeg"
image_positive_thumbnail_id_1="679"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0029.jpeg"
image_positive_thumbnail_id_2="948"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0110.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1191"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
